WCLC 2025 - Posters & ePosters-P2.15 .18 Quality of Life for Lung Cancer Survivors

Pdf Summary

This study investigates the quality of life (QOL) among lung cancer survivors (LCS), recognizing lung cancer as the leading cause of cancer-related deaths in the US and the growing population of survivors needing focused research. Patients treated at Johns Hopkins from 2020 to 2024 who survived at least one year post-diagnosis completed the EORTC QLQ-C30 survey assessing their daily activity engagement and symptom burden; higher scores reflect better quality of life.<br /><br />The analysis included 307 survivors (60% female, 61% aged 65 or older, majority Caucasian) with varying cancer stages (38% stage I-II, 19% stage III, 43% stage IV) and treatment lines. Key findings reveal that LCS who underwent three or more lines of therapy reported higher quality of life, as did retired individuals compared to employed or unemployed patients. In contrast, factors such as sex, age, race, cancer stage at diagnosis, household income, education level, and treatment intent (curative vs. palliative) showed no statistically or clinically significant association with QOL scores.<br /><br />The results emphasize the need for future research to develop targeted interventions focusing on lung cancer survivors at higher risk of impaired quality of life due to sociodemographic factors. The study underscores the importance of identifying and supporting subgroups within the survivor population to improve post-treatment well-being, despite traditional demographic and clinical variables showing limited impact on their quality of life.<br /><br />Overall, this work contributes to understanding the complexity of quality of life outcomes in lung cancer survivors, suggesting areas for intervention beyond clinical and demographic characteristics to better support this growing patient population.

Asset Subtitle

Asha Kodan

Meta Tag

Speaker Asha Kodan

Topic Multidisciplinary Care: Nursing, Allied Health and Palliative Care

Keywords

lung cancer survivors

quality of life

EORTC QLQ-C30

cancer stages

treatment lines

sociodemographic factors

post-treatment well-being

Johns Hopkins study

symptom burden

targeted interventions